A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantation

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Rusnak F, Mertz P. Calcineurin: form and function. Physiol. Rev. 80(4), 1483–1521 (2000).
  Medline CASGoogle Scholar
• 2 Barbarino JM, Staatz CE, Venkataramanan R et al.. PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenet. Genomics 23(10), 563–585 (2013).
  Medline CASGoogle Scholar
• 3 Böhler T, Nolting J, Kamar N et al. Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans. Ther. Drug Monit. 29(1), 77–86 (2007).
  MedlineGoogle Scholar
• 4 Noceti OM, Woillard J-B, Boumediene A et al. Tacrolimus pharmacodynamics and pharmacogenetics along the calcineurin pathway in human lymphocytes. Clin. Chem. 60(10), 1336–1345 (2014).
  Medline CASGoogle Scholar
• 5 Picard N, Marquet P. The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation. Expert Opin. Drug Metab. Toxicol. 7(6), 731–743 (2011).
  Medline CASGoogle Scholar
• 6 Moscoso-Solorzano GT, Ortega F, Rodríguez I et al. A search for cyclophilin-A gene variants in cyclosporine A-treated renal transplanted patients. Clin. Transplant. 22(6), 722–729 (2008).• A report associating PPIA rs8177826 with nephrotoxicity in renal transplant recipients.
  MedlineGoogle Scholar
• 7 Seyhun Y, Mytilineos J, Turkmen A et al. Influence of cytokine gene polymorphisms on graft rejection in Turkish patients with renal transplants from living related donors. Transplant. Proc. 44(6), 1670–1678 (2012).• A study showing that IL2 rs2069763 associates with acute rejection in renal transplant recipients.
  Medline CASGoogle Scholar
• 8 Morgun A, Shulzhenko N, Rampim GF et al. Interleukin-2 gene polymorphism is associated with renal but not cardiac transplant outcome. Transplant. Proc. 35(4), 1344–1345 (2003).• A higher frequency of IL2 rs2069762 TT genotype was found in renal transplant recipients experiencing at least one biopsy proven acute rejection episode.
  Medline CASGoogle Scholar
• 9 Rits MAN, van Dort KA, Kootstra NA. Polymorphisms in the regulatory region of the cyclophilin A gene influence the susceptibility for HIV-1 infection. PLoS ONE 3(12), e3975 (2008).
  MedlineGoogle Scholar
• 10 An P, Wang LH, Hutcheson-Dilks H et al. Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS. PLoS Pathog. 3(6), e88 (2007).
  MedlineGoogle Scholar
• 11 Palacín M, Rodríguez I, García-Castro M et al. A search for cyclophilin-A gene (PPIA) variation and its contribution to the risk of atherosclerosis and myocardial infarction. Int. J. Immunogenet. 35(2), 159–164 (2008).
  Medline CASGoogle Scholar
• 12 Le Meur Y, Büchler M, Thierry A et al. Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation. Am. J. Transplant. 7(11), 2496–2503 (2007).
  Medline CASGoogle Scholar
• 13 Le Meur Y, Thierry A, Glowacki F et al. Early steroid withdrawal and optimization of mycophenolic acid exposure in kidney transplant recipients receiving mycophenolate mofetil. Transplantation 92(11), 1244–1251 (2011).
  Medline CASGoogle Scholar
• 14 Medical Dictionary for Regulatory Activities. www.meddra.org.
  Google Scholar
• 15 Untergasser A, Nijveen H, Rao X, Bisseling T, Geurts R, Leunissen JAM. Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res. 35, W71–W74 (2007).
  MedlineGoogle Scholar
• 16 Chiocco MJ, Zhu X, Walther D et al. Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5′UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer's disease. Subst. Use Misuse 45(11), 1809–1826 (2010).
  MedlineGoogle Scholar
• 17 Tang W, Arnett DK, Devereux RB et al. Identification of a novel 5-base pair deletion in calcineurin B (PPP3R1) promoter region and its association with left ventricular hypertrophy. Am. Heart J. 150(4), 845–851 (2005).
  Medline CASGoogle Scholar
• 18 Ahmetov II, Williams AG, Popov DV et al. The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. Hum. Genet. 126(6), 751–761 (2009).
  Medline CASGoogle Scholar
• 19 Cruchaga C, Kauwe JSK, Mayo K et al. SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease. PLoS Genet. 6(9), e1001101 (2010).
  MedlineGoogle Scholar
• 20 Zhao D, Qiu G-X, Wang Y-P. Is calmodulin 1 gene/estrogen receptor-alpha gene polymorphisms correlated with double curve pattern of adolescent idiopathic scoliosis? Zhonghua Yi Xue Za Zhi 88(35), 2452–2456 (2008).
  Medline CASGoogle Scholar
• 21 Mototani H, Mabuchi A, Saito S et al. A functional single nucleotide polymorphism in the core promoter region of CALM1 is associated with hip osteoarthritis in Japanese. Hum. Mol. Genet. 14(8), 1009–1017 (2005).
  Medline CASGoogle Scholar
• 22 Zhuang Q, Wu Z, Qiu G. Is polymorphism of CALM1 gene or growth hormone receptor gene associated with susceptibility to adolescent idiopathic scoliosis? Zhonghua Yi Xue Za Zhi 87(31), 2198–2202 (2007).
  Medline CASGoogle Scholar
• 23 Hoffmann SC, Stanley EM, Darrin Cox E et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 72(8), 1444–1450 (2001).
  Medline CASGoogle Scholar
• 24 Hussain SK, Madeleine MM, Johnson LG et al. Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2. Cancer Epidemiol. Biomark. 17(7), 1790–1799 (2008).
  Medline CASGoogle Scholar
• 25 Satoh S, Saito M, Inoue K, Miura M, Komatsuda A, Habuchi T. Association of cytokine polymorphisms with subclinical progressive chronic allograft nephropathy in Japanese renal transplant recipients: preliminary study. Int. J. Urol. 14(11), 990–994 (2007).
  Medline CASGoogle Scholar
• 26 Oetting WS, Schladt DP, Leduc RE et al. Validation of single nucleotide polymorphisms associated with acute rejection in kidney transplant recipients using a large multi-center cohort. Transpl. Int. 24(12), 1231–1238 (2011).
  Medline CASGoogle Scholar
• 27 Yucesoy B, Johnson VJ, Fluharty K et al. Influence of cytokine gene variations on immunization to childhood vaccines. Vaccine 27(50), 6991–6997 (2009).
  Medline CASGoogle Scholar
• 28 Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens 72(3), 211–220 (2008).
  Medline CASGoogle Scholar
• 29 van Heel DA, Franke L, Hunt KA et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet. 39(7), 827–829 (2007).
  Medline CASGoogle Scholar
• 30 Márquez A, Orozco G, Martínez A et al. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease. Am. J. Gastroenterol. 104(8), 1968–1975 (2009).
  Medline CASGoogle Scholar
• 31 Hollis-Moffatt JE, Chen-Xu M, Topless R et al. Only one independent genetic association with rheumatoid arthritis within the KIAA1109–TENR–IL2–IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance. Arthritis Res. Ther. 12(3), R116 (2010).
  MedlineGoogle Scholar
• 32 Zhernakova A, Alizadeh BZ, Bevova M et al. Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of Type 1 diabetes point to a general risk locus for autoimmune diseases. Am. J. Hum. Genet. 81(6), 1284–1288 (2007).
  Medline CASGoogle Scholar
• 33 Fichna M, Zurawek M, Fichna P, Ziółkowska-Suchanek I, Januszkiewicz D, Nowak J. Polymorphic variant at the IL2 region is associated with Type 1 diabetes and may affect serum levels of interleukin-2. Mol. Biol. Rep. 40(12), 6957–6963 (2013).
  Medline CASGoogle Scholar
• 34 International Multiple Sclerosis Genetics Consortium, Hafler DA, Compston A et al. Risk alleles for multiple sclerosis identified by a genome-wide study. N. Engl. J. Med. 357(9), 851–862 (2007).
  MedlineGoogle Scholar
• 35 D'Netto MJ, Ward H, Morrison KM et al. Risk alleles for multiple sclerosis in multiplex families. Neurology 72(23), 1984–1988 (2009).
  MedlineGoogle Scholar
• 36 Kurreeman FAS, Daha NA, Chang M et al. Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population. Ann. Rheum. Dis. 68(11), 1789–1790 (2009).
  Medline CASGoogle Scholar
• 37 Alcina A, Fedetz M, Ndagire D et al. IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and Type 1 diabetes (T1D). PLoS ONE 4(1), e4137 (2009).
  MedlineGoogle Scholar
• 38 Srivastava B, Mells GF, Cordell HJ et al. Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis. Scand. J. Gastroenterol. 47(7), 820–826 (2012).
  Medline CASGoogle Scholar
• 39 Schmied MC, Zehetmayer S, Reindl M et al. Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients. Neurogenetics 13(2), 181–187 (2012).
  Medline CASGoogle Scholar
• 40 Carr EJ, Clatworthy MR, Lowe CE et al. Contrasting genetic association of IL2RA with SLE and ANCA-associated vasculitis. BMC Med. Genet. 10, 22 (2009).
  MedlineGoogle Scholar
• 41 Lowe CE, Cooper JD, Brusko T et al. Large-scale genetic fine mapping and genotype–phenotype associations implicate polymorphism in the IL2RA region in Type 1 diabetes. Nat. Genet. 39(9), 1074–1082 (2007).
  Medline CASGoogle Scholar
• 42 Qu H-Q, Bradfield JP, Bélisle A et al. The Type I diabetes association of the IL2RA locus. Genes Immun. 10(Suppl. 1), S42–S48 (2009).
  Medline CASGoogle Scholar
• 43 Qu H-Q, Montpetit A, Ge B, Hudson TJ, Polychronakos C. Toward further mapping of the association between the IL2RA locus and Type 1 diabetes. Diabetes 56(4), 1174–1176 (2007).
  Medline CASGoogle Scholar
• 44 Redler S, Albert F, Brockschmidt FF et al. Investigation of selected cytokine genes suggests that IL2RA and the TNF/LTA locus are risk factors for severe alopecia areata. Br. J. Dermatol. 167(6), 1360–1365 (2012).
  Medline CASGoogle Scholar
• 45 Ban Y, Tozaki T, Taniyama M et al. Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population. Thyroid 20(8), 893–899 (2010).
  Medline CASGoogle Scholar
• 46 Babron M-C, Perdry H, Handel AE et al. Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis. Eur. J. Hum. Genet. 20(3), 321–325 (2012).
  Medline CASGoogle Scholar
• 47 Aslibekyan S, Kabagambe EK, Irvin MR et al. A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network. Pharmacogenet. Genomics 22(3), 191–197 (2012).
  Medline CASGoogle Scholar
• 48 Perera D, Stankovich J, Butzkueven H et al. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus. J. Neuroimmunol. 211(1–2), 105–109 (2009).
  Medline CASGoogle Scholar
• 49 R Foundation for Statistical Computing. www.r-project.org.
  Google Scholar
• 50 Paramesh AS, Zhang R, Baber J et al. The effect of HLA mismatch on highly sensitized renal allograft recipients. Clin. Transplant. 24(6), E247–E252 (2010).
  MedlineGoogle Scholar
• 51 Abdi ZD, Prémaud A, Essig M et al. Exposure to mycophenolic acid better predicts immunosuppressive efficacy than exposure to calcineurin inhibitors in renal transplant patients. Clin. Pharmacol. Ther. 96(4), 508–515 (2014).
  MedlineGoogle Scholar
• 52 Pallardó Mateu LM, Sancho Calabuig A, Capdevila Plaza L, Franco Esteve A. Acute rejection and late renal transplant failure: risk factors and prognosis. Nephrol. Dial. Transplant. 19(Suppl. 3), iii38–iii42 (2004).
  MedlineGoogle Scholar
• 53 Pouché L, Avcu K, Esperón P, Noceti OM, Marquet P, Picard N. Genetic databases and their pitfalls: an example related to pharmacogenetics. Ther Drug Monit. 35(5), 713–714 (2013).
  Google Scholar
• 54 Pouché L, Stojanova J, Marquet P, Picard N. New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs. Pharmacogenomics (2016) (Epub ahead of print).•• A comprehensive review of candidates genes of the calcineurin pathway with reports of previous associations with different phenotypes and highlights on the most promising candidates for pharmacogenetic studies in solid organ transplantation.
  Google Scholar
• 55 Ekberg H, Tedesco-Silva H, Demirbas A et al. ELITE-Symphony Study. Reduced exposure to calcineurin inhibitors in renal transplantation. N. Engl. J. Med. 357(25), 2562–2575 (2007).
  Medline CASGoogle Scholar
• 56 Picard N, Bergan S, Marquet P et al. Pharmacogenetic biomarkers predictive of the pharmacokinetics and pharmacodynamics of immunosuppressive drugs. Ther. Drug Monit. PMID: 26469711 (2015) (Epub ahead of print).
  Google Scholar
• 57 Lefaucheur C, Nochy D, Hill GS et al. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am. J. Transplant. 7(4), 832–841 (2007).
  Medline CASGoogle Scholar
• 58 George S, Turner D, Reynard M et al. Significance of cytokine gene polymorphism in renal transplantation. Transplant. Proc. 33(1–2), 483–484 (2001).
  Medline CASGoogle Scholar
• 59 Hoffmann S, Park J, Jacobson LM et al. Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int. 66(4), 1686–1693 (2004).
  Medline CASGoogle Scholar
• 60 Manchanda PK, Mittal RD. Analysis of cytokine gene polymorphisms in recipient's matched with living donors on acute rejection after renal transplantation. Mol. Cell. Biochem. 311(1–2), 57–65 (2008).
  Medline CASGoogle Scholar
• 61 Grinyó J, Vanrenterghem Y, Nashan B et al. Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl. Int. 21(9), 879–891 (2008).
  Medline CASGoogle Scholar
• 62 Karimi MH, Daneshmandi S, Pourfathollah AA et al. A study of the impact of cytokine gene polymorphism in acute rejection of renal transplant recipients. Mol. Biol. Rep. 39(1), 509–515 (2012).
  Medline CASGoogle Scholar
• 63 Chen Z, Bouamar R, Van Schaik RHN et al. Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patients. Clin. Transplant. 28(6), 649–655 (2014).
  Medline CASGoogle Scholar
• 64 Moore J, McKnight AJ, Döhler B et al. Donor ABCB1 variant associates with increased risk for kidney allograft failure. J. Am. Soc. Nephrol. 23(11), 1891–1899 (2012).
  Medline CASGoogle Scholar
• 65 Naim I. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. Am. J. Nephrol. 37(6), 602–612 (2013).
  MedlineGoogle Scholar
• 66 Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin. J. Am. Soc. Nephrol. 4(2), 481–508 (2009).
  Medline CASGoogle Scholar
• 67 Sibbring JS, Sharma A, McDicken IW, Sells RA, Christmas SE. Localization of C-X-C and C-C chemokines to renal tubular epithelial cells in human kidney transplants is not confined to acute cellular rejection. Transpl. Immunol. 6(4), 203–208 (1998).
  Medline CASGoogle Scholar
• 68 Hoffmann S, Park J, Jacobson LM et al. Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int. 66(4), 1686–1693 (2004).
  Medline CASGoogle Scholar
• 69 Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am. J. Transplant. 4(4), 583–595 (2004).
  MedlineGoogle Scholar